Based out of the Boston area, Dr. Dormitzer will start his role at GlaxoSmithKline on Dec. 3.
Dr. Dormitzer joins GlaxoSmithKline from Pfizer, where he served as vice president and chief scientific officer for viral vaccines and provided scientific leadership for the development of Pfizer’s COVID-19 vaccine.
“GSK has an industry-leading pipeline of vaccines, and Phil’s scientific expertise and significant experience with key innovative technologies, such as mRNA, structure-based antigen design and synthetic biology, will be key to ensuring we remain a leader in this field,” Hal Barron, MD, GlaxoSmithKline’s chief scientific officer and president of research and development, said in a news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
